Is there an association of regulatory region polymorphism in the alpha-1-antichymotrypsin gene with sporadic Alzheimer's disease in the northern Han-Chinese population?

Journal of Clinical Neuroscience

Volumn 17, Issue 6, 2010, Pages 766-769

  Yu, Guran ^a   Jia, Jianping ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alpha 1 antichymotrypsin; Alzheimer's disease; Haplotype; Polymorphism; Regulatory region

Indexed keywords

ADENINE; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTICHYMOTRYPSIN 1; ALPHA 1 ANTICHYMOTRYPSIN 2; ALPHA 1 ANTICHYMOTRYPSIN 3; ALPHA 1 ANTICHYMOTRYPSIN 4; APOLIPOPROTEIN E4; CHYMOTRYPSIN INHIBITOR; CYSTEINE; GUANINE; THYMINE; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 77953127348     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.10.017     Document Type: Article

References (26)

1. Abraham C.R., Selkoe D.J., and Potter H. Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52 (1988) 451-487
2. Baker C., Nielsen H.M., Minthon L., et al. Effects of Alzheimer's peptide and 1-antichymotrypsin on astrocyte gene expression. Neurobiol Aging 28 (2007) 51-61
3. Janciauskiene S., Eriksson S., and Wright H.T. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin. Nat Struct Biol 3 (1996) 668-671
4. Janciauskiene S., Rubin H., Lukacs C.M., et al. Alzheimer's peptide A beta 1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate. J Biol Chem 273 (1998) 28360-28364
5. Ma J., Yee A., Brewer Jr. H.B., et al. Amyloid-associated proteins alpha antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372 (1994) 92-94
6. *4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 10 (1995) 486-488
7. Wang X., DeKosky S.T., Luedecking-Zimmer E., et al. Genetic variation in α1-antichymotrypsin and its association with Alzheimer's disease. Hum Genet 110 (2002) 356-365
8. Kamboh M.I., Minster R.L., Kenney M., et al. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. Neurobiol Aging 27 (2006) 1435-1439
9. Itabashi S., Arai H., Matsui T., et al. Absence of association of alpha 1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases. Exp Neurol 151 (1998) 237-240
10. Meng G., Yuan J., An L., et al. An association study of polymorphisms in the alpha-antichymotrypsin gene for Alzheimer disease in Han-Chinese. Hum Mutat 16 (2000) 275-276
11. Murphy Jr. G.M., Sullivan E.V., Gallagher-Thompson D., et al. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease. Neurology 48 (1997) 1313-1316
12. Wang Y.C., Liu T.Y., Liu H.C., et al. No association between alpha1-antichymotrypsin polymorphism and Alzheimer's disease in Chinese. Neuropsychobiology 40 (1999) 67-70
13. Kordula T., Rydel R.E., Brigham E.F., et al. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 273 (1998) 4112-4118
14. Licastro F., Chiappelli M., Grimaldi L.M., et al. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Neurobiol Aging 26 (2005) 449-453
15. Morgan K., Licastro F., Tilley L., et al. Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations. Hum Genet 109 (2001) 303-310
16. Ritchie A., Morgan K., and Kalsheker N. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism. Brain Res Mol Brain Res 131 (2004) 88-92
17. Licastro F., Chiappelli M., Thal L.J., et al. Alpha-1-antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease. Arch Gerontol Geriatr Suppl 9 (2004) 243-251
18. Belbin O., Dunn J.L., Chappell S., et al. A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD. Neurobiol Aging 29 (2008) 1167-1176
19. Gopalan S.M., Wilczynska K.M., Konik B.S., et al. Strocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes requires activator protein-1. J Biol Chem 281 (2006) 1956-1963
20. Kordula T., Bugno M., Rydel R.E., et al. Mechanism of interleukin-1- and tumor necrosis factor alpha-dependent regulation of the alpha 1-antichymotrypsin gene in human astrocytes. J Neurosci 20 (2000) 7510-7516
21. Shi Y.Y. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2005) 97-98
22. Akey J., Jin L., and Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain?. Eur J Hum Genet 9 (2001) 291-300
23. Clark A.G. The role of haplotypes in candidate gene studies. Genet Epidemiol 27 (2004) 321-333
24. Daly M.J., Rioux J.D., Schaffner S.F., et al. High-resolution haplotype structure in the human genome. Nat Genet 29 (2001) 229-232
25. Goldstein D.B. Islands of linkage disequilibrium. Nat Genet 29 (2001) 109-111
26. Schaid D.J. Evaluating associations of haplotypes with traits. Genet Epidemiol 27 (2004) 348-364